Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?

OBJECTIVE: Androgen deprivation therapy (ADT) is beneficial for unfavorable intermediate-risk (IR) prostate cancer patients receiving curative radiotherapy (RT). However, for favorable IR patients the latest NCCN guidelines recommends RT alone. We retrospectively studied treatment patterns and outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Amit, Uri, Lawrence, Yaacov R., Weiss, Ilana, Symon, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558831/
https://www.ncbi.nlm.nih.gov/pubmed/31182119
http://dx.doi.org/10.1186/s13014-019-1298-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558831/
https://www.ncbi.nlm.nih.gov/pubmed/31182119
http://dx.doi.org/10.1186/s13014-019-1298-9

Ejemplares similares